GLP-1 Drugs For Weight Loss Aren’t Cost-Saving Yet
Intuitively, it would seem that GLP-1 use for obesity would reduce overall medical costs despite the increase in drug ...
1 in 8 People in the U.S. Has Taken a GLP-1 Drug and Food Brands Are Taking Notice
One in eight people living in the United States has taken a GLP-1 medication — such as Ozempic, Mounjaro, or Zepbound — for ...
Why GLP-1 Drugs Are Real Threat To McDonald's Golden Arches
McDonald's shares underperformed in 2024, likely due to the rise of GLP-1 medications. Learn why MCD stock is a Sell.
Study finds no elevated risk of thyroid cancer among GLP1-RA users
A study has found no evidence that glucagon-like peptide 1 receptor agonist (GLP1-RA) use is associated with an increased ...
I’m a weight-loss doctor — the unusual complication I’m seeing from Ozempic-like drugs
A top NYC weight-loss doctor shared the surprising skin complication that he’s encountered in patients using GLP-1 drugs like ...
Rolling Out13d
Bariatric surgery proves more powerful than weight loss drugs
While GLP-1 medications like Ozempic and Wegovy have garnered significant attention, bariatric surgery continues to ...
Convenience Store News7d
Circana Talks ‘Profound Impact’ GLP-1 Drugs Have on Spending for Food, Beverages, More
This is the beginning of a revolution, and how you engage and how you attack it is going to really set the stage for your ...
Less than 50% of employers cover GLP-1 drugs for weight loss: JPM survey
"Coverage for these weight-loss drugs has significant cost implications for employers, as a previous KFF analysis estimated ...